Trial intelligence / Profile preview

Promestriene for preoperative treatment of severe hypospadias

NCT01370798Phase 3Completed

Sponsor
Hospices Civils de Lyon
Start
May 2011
Primary completion
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hypospadias comparing promestriene with Placebo (2 arms). Primary endpoint: Number of patients with postoperative urethral fistula and dehiscence at 1 year. Started May 2011; status: completed.

02

Drugs

promestriene
03

Conditions

hypospadias

Beyond the preview

Go deeper on NCT01370798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01370798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call